Getinge announced that it appointed three new executives, including a new president of its business for the North America region.
Gothenburg, Sweden-based Getinge confirmed that Patricia Fitch will succeed Eric Honroth as president of the North America region. Honroth has been appointed as president of life science at Getinge.
Additionally, Elin Frostehav, who had been serving as VP of critical care within the acute care therapies business, has been appointed as president of acute care therapies.
Fitch holds more than 30 years of medical device experience, having served in leadership roles in sales, marketing and operations at companies including Johnson & Johnson, Abiomed, St. Jude Medical and 3M.
Honroth joined Getinge in 2018 and has more than 20 years of experience in medical device leadership, with previous positions held at BD, CareFusion and Abbott. He succeeds Harald Castler, who is retiring.
Frostehav joined Getinge in 2019, having previously served in leading global positions with Semcon. Frostehav, who also previously held a number of positions at FlexLink, takes over for Jens Viebke, who is now Getinge’s EVP of research & business development.
All personnel changes made by Getinge are effective April 1, 2022.
